编织型支架与激光切割型支架用于不可切除远端恶性胆道梗阻患者的随机对照试验
本研究为随机对照试验,将60例不可切除远端恶性胆道梗阻患者随机分入激光切割型支架组和编织型支架组,最终56例纳入分析(激光切割型组27例,编织型组29例)。主要终点为1年内复发性胆道梗阻率,激光切割型组为44.4%,编织型组为17.2%(比值比2.57,95%CI 1.045-6.353)。编织型支架组中位至复发性胆道梗阻时间显著长于激光切割型支架组,两组中位总生存期无显著差异。
要点
- 不可切除远端恶性胆道梗阻患者中,编织型支架1年内复发性胆道梗阻率低于激光切割型支架。
- 编织型支架组中位至复发性胆道梗阻时间显著长于激光切割型支架组。
- 两组早期不良事件(胰腺炎、胆囊炎)经保守治疗好转,安全性无差异。
核心结论
- 在远端恶性胆道梗阻患者中,编织型支架较激光切割型支架复发性胆道梗阻更少,但安全性无差异。
研究设计与样本
- 随机对照试验,将诊断为不可切除远端恶性胆道梗阻的患者按分层区组方式随机分配至激光切割型支架组和编织型支架组。
- 共入组60例,最终56例纳入分析(激光切割型组27例,编织型组29例)。
主要发现
- 1年内复发性胆道梗阻率激光切割型组为44.4%,编织型组为17.2%(比值比2.57,95%CI 1.045-6.353)。
- 早期不良事件经保守治疗好转,激光切割型组胰腺炎4例,编织型组胰腺炎3例和胆囊炎1例(P=.913)。
- 中位至复发性胆道梗阻时间编织型组418天(95%CI 232-454)显著长于激光切割型组220天(95%CI 56-272)(log-rank检验,P=.0118)。
- 支架置入后中位总生存期激光切割型组158天,编织型组204天,两组间无显著差异(P=.8544)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Fully covered self-expandable metallic stents (SEMSs) are laser-cut (L) or braided (B); however, it remains unclear which approach is more effective for distal malignant biliary obstruction (DMBO). This study compared the clinical outcomes of using L-type and B-type stents because we believe that recurrent biliary obstruction (RBO) is less likely to occur with L-type stents. METHODS: Patients diagnosed with unresectable DMBO were randomly assigned to groups L and B in a stratified block fashion, and outcomes were compared. The primary outcome was the rate of RBO within 1 year; secondary outcomes were adverse events, clinical success rate, time to RBO (TRBO), and overall survival. RESULTS: Of the 60 enrolled participants, 56 (group L, n = 27; group B, n = 29) were included. The rates of RBO within 1 year were 44.4% and 17.2% in groups L and B, respectively (odds ratio, 2.57; 95% confidence interval [CI], 1.045-6.353). Early adverse events, which improved with conservative treatment, included pancreatitis (n = 4) in group L and pancreatitis (n = 3) and cholecystitis (n = 1) in group B (P = .913). The median TRBO (220 days [95% CI, 56-272] vs 418 days [95% CI, 232-454]) was significantly longer in group B than in group L (log-rank test, P = .0118). The median overall survival (group L, 158 days; group B, 204 days) after stenting was not significantly different between groups (P = .8544). CONCLUSIONS: In the setting of DMBO, B-type stents are associated with less recurrent obstruction than L-type stents, although there was no difference in safety. (UMIN Clinical Trials Registry number: UMIN000027239.).
引用
- Hasegawa S, Sato T, Shinoda S, et al. Braided-type stent versus laser-cut-type stent for patients with unresectable distal malignant biliary obstruction: a randomized controlled trial. Gastrointest Endosc. 2023. PMID: 38065510. doi:10.1016/j.gie.2023.11.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。